Vasamed, Inc. designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system. It serves clinicians and patients. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota.
Frequently asked questions
What sector does Vasamed Inc (VSMD) operate in?
Vasamed Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Vasamed Inc (VSMD) current stock price?
As of the latest data, Vasamed Inc stock price is $0.00, with a previous close of $0.00.
What is Vasamed Inc (VSMD) current market capitalization?
Vasamed Inc market cap is approximately 2.89 million.
Does Vasamed Inc (VSMD) pay dividends?
No. Vasamed Inc does not pay a dividend.
What is Vasamed Inc (VSMD) beta (volatility) score?
Vasamed Inc has a beta of -1.058, indicating lower volatility than the overall market.